Analyst Report: LRCX
1. EXECUTIVE SUMMARY
Lam Research fell 11.76% to $230.15 on Thursday 22 October 2026, the session after its fiscal first-quarter 2027 report, because the December-quarter guide and CEO Tim Archer's comments on supply limits overshadowed a quarter that beat estimates. Management guided revenue to $8.6 billion, plus or minus $400 million, and said supply-chain constraints held that figure below what demand would support. Archer expects cleanroom space and certain component supply to limit chipmakers' output into calendar 2027, and the market read this as an industry-wide ceiling. Applied Materials, KLA, Teradyne and Qnity-type peers in the group fell between 8.16% and 10.63%, so Lam took the sharpest hit in its group. Three brokers cut targets and kept positive ratings. Management says delayed shipments move into the March quarter, which makes the first half of 2027 the test of whether this is a timing slip.
2. THE CATALYST
Lam reported after the close on 21 October. The stock had closed that day at $260.81, and the reaction came in the 22 October session on volume of 22,957,600 shares, 2.64x the 50-session average.
| Item | Figure | Source |
|---|---|---|
| Revenue | $8.22bn, +22% sequentially, +54% year over year | TradingKey, BigGo Finance |
| Adjusted EPS | $2.20 vs $2.18 expected | TradingKey, BigGo Finance |
| Operating margin | 40.2%, first time above 40% | TradingKey |
| Gross margin | 52.4% | TradingKey |
| December-quarter revenue guide | $8.6bn ± $400m | AOL transcript, GuruFocus |
| December-quarter EPS guide | $2.33 ± $0.15 | AOL transcript |
Per the AOL transcript, Archer said cleanroom space and some component supply would keep limiting chipmaker output into calendar 2027. Stocktwits and 24/7 Wall St. reported that semiconductor stocks reversed on Thursday after those comments. Management also expects China revenue, 35% of the first quarter, to fall significantly in the December quarter as domestic customers' shipments normalize (BigGo Finance, GuruFocus).
Sources gave differing sizes for the after-hours decline on 21 October, so no figure is quoted here.
3. COMPANY PROFILE
Lam Research (Technology, Semiconductor Equipment & Materials) makes semiconductor processing equipment for deposition and etch, including ALTUS, SABRE and Striker systems, and refurbishes and services the installed base. Its market competitors in the group include Applied Materials, KLA and Teradyne. The market capitalisation is $288.02bn, with a forward P/E of 19.6 and a trailing P/E of 40.0.
From the brief: the company expects a fifth straight quarterly revenue record, with memory at 46% of systems revenue and NAND up roughly 40% sequentially (TradingKey). Management sees preliminary calendar 2027 wafer-fab equipment spending above $200 billion (TradingKey). Bernstein's note says the company expects customer-support revenue growth above 15% and anticipates a sharply larger buyback (Investing.com).
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The reported quarter was strong: 54% annual revenue growth and record margins. The guide sits at $8.6 billion against $8.22 billion reported, which is roughly 5% sequential growth at the midpoint, a slower pace than the 22% just delivered (inference from the brief's figures). The company attributes the shortfall to supply rather than demand, and says slipped shipments land in the March quarter (Investing.com). A fall of 11.76% prices in some risk that supply limits persist, and that China weakens further.
Peer read-across.
| Peer | Move, same period |
|---|---|
| AMAT | -8.16% |
| KLAC | -9.55% |
| TER | -10.63% |
| Q | -9.48% |
| LRCX | -11.76% |
The S&P 500 fell 1.21%. According to 24/7 Wall St., selling concentrated in chip names tied to AI data-centre spending, with AMD, Marvell and Intel showing the largest declines, while Stocktwits reported Nvidia, Micron and AMD also fell. Stocktwits adds that chip stocks had rebounded early in the week after a sharp selloff the week before, and Thursday reversed that rebound. The shared decline across equipment makers and chip designers suggests the market treated Archer's remarks as a sector statement. That is inference.
Analyst reaction. Targets fell while ratings held.
| Broker | Target change | Rating |
|---|---|---|
| BofA Securities | $385 to $345 | Buy |
| Needham | $390 to $290 | Buy |
| Bernstein SocGen | $385 to $350 | Outperform |
All three cited supply constraints (Investing.com). A TradingView headline cites a $372.07 target cut, which is unconfirmed. The brief contains no sourced comparable episodes.
Bull case. Demand exceeds supply, with calendar 2027 wafer-fab equipment spending above $200 billion, delayed shipments recovering in March, a larger buyback and a forward P/E of 19.6.
Bear case. Supply limits cap growth through 2027, China revenue falls significantly after a 35% share, and AI-linked sentiment has turned across the sector. The stock now trades 47.5% below its 52-week high of $438.03.
5. TECHNICAL SNAPSHOT
The close of $230.15 is the lowest in the ten-session table and sits below the 50-day average of $304.35 and the 200-day average of $282.88, so no nearby support level appears in the recent closes. The stock is down 17.05% over five sessions and 25.07% over twenty. It remains well above the 52-week low of $134.88 and is up 24.73% year to date. Volume of 22,957,600 followed 16,027,300 on 21 October, and both sit well above the 50-session average of 8,705,444, which shows heavy participation in the selloff. The session's low of $227.68 was close to the final price. The nearest resistance is the 16 October close of $263.94.
6. RISK FACTORS
- Supply limits on cleanroom space and components extend beyond calendar 2027, as Archer indicated.
- China revenue falls by more than management indicates.
- Delayed shipments fail to appear in the March quarter.
- Further sector selling tied to AI data-centre spending.
- Broker targets move lower again; three cuts came in one day.
Dated catalysts: management expects to sharpen its 2027 wafer-fab equipment outlook on the January call (GuruFocus). The brief gives no exact date for the December-quarter report, and the facts panel carries no earnings date either. The March-quarter shipments are the first test of the timing slip (Investing.com).
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks): The stock is oversold after a 25.07% decline over twenty sessions, yet the guide and supply message remain unchanged. Price action follows chip-sector direction, so moves in Nvidia, Micron and AMD matter. A recovery toward $263.94 would be the first sign of stabilisation; a close below $227.68 would extend the decline.
Medium term (1-3 months): The January call and any update to the $200 billion-plus 2027 equipment estimate drive the stock. Evidence that supply constraints ease would favour a recovery, while a further China decline or additional guide cuts would favour more downside.
Long term: The thesis rests on a 2027 equipment cycle that management sees above $200 billion, and the supply message delays rather than removes that revenue, according to the company. The brief gives no evidence of weaker demand, so the thesis is unchanged for now, with timing the open question. This is analysis, not personal financial advice.